Viewing StudyNCT00104975



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00104975
Status: COMPLETED
Last Update Posted: 2016-12-15
First Post: 2005-03-03

Brief Title: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Sponsor: Yale University
Organization: Yale University

Conditions & Keywords Data

Conditions:
Name
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Myelodysplastic Syndromes
MyelodysplasticMyeloproliferative Neoplasms
Keywords:
Name View
atypical chronic myeloid leukemia BCR-ABL1 negative View
accelerated phase chronic myelogenous leukemia View
recurrent adult Burkitt lymphoma View
stage IV adult Burkitt lymphoma View
recurrent adult lymphoblastic lymphoma View
stage IV adult lymphoblastic lymphoma View
recurrent adult immunoblastic large cell lymphoma View
stage IV adult immunoblastic large cell lymphoma View
refractory anemia with excess blasts in transformation View
refractory anemia with excess blasts View
secondary myelodysplastic syndromes View
chronic myelomonocytic leukemia View
blastic phase chronic myelogenous leukemia View
chronic eosinophilic leukemia View
primary myelofibrosis View
chronic neutrophilic leukemia View
essential thrombocythemia View
polycythemia vera View
adult acute myeloid leukemia in remission View
adult acute myeloid leukemia with 11q23 MLL abnormalities View
adult acute myeloid leukemia with inv16p13q22 View
adult acute myeloid leukemia with t1517q22q12 View
adult acute myeloid leukemia with t1616p13q22 View
adult acute myeloid leukemia with t821q22q22 View
recurrent adult acute myeloid leukemia View
refractory chronic lymphocytic leukemia View
stage III chronic lymphocytic leukemia View
stage IV chronic lymphocytic leukemia View
stage III adult Burkitt lymphoma View
stage III adult immunoblastic large cell lymphoma View
stage III adult lymphoblastic lymphoma View
myelodysplasticmyeloproliferative neoplasm unclassifiable View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View